| Sub Cat | Immunogen | Isotype | Application | Affinity | |
|---|---|---|---|---|---|
| V3S-1124-YC402 | IgG | FuncS | |||
| V3S-0622-YC2219 | IgG | IP; IF; FuncS; FC; Neut; ELISA; ICC | |||
| V3S-0622-YC4925 | Human CD20 transfected NS/0 cells | IgG3 kappa | FuncS | ||
| V3S-0622-YC4989 | IgG | ELISA; FC; IP; FuncS; IF; Neut; WB | |||
| V3S-0622-YC4996 | IgG | Neut; ELISA; IF; IP; FuncS; FC; ICC | |||
| V3S-0522-YC3246 | IgG | ELISA; FC; FuncS | |||
| V3S-0522-YC3250 | IgG | FC | |||
| V3S-0522-YC3251 | IgG | FC; FuncS | |||
| V3S-0522-YC3252 | IgG | FuncS | |||
| V3S-0522-YC635 | IgG | ELISA; FC | |||
| V3S-0522-YC7936 | Human membrane-spanning 4-domains, subfamily A, member 1 | IgG | WB; IF; FuncS | ||
| V3S-0522-YC8081 | IgG1 lambda | WB; ELISA; FuncS | |||
| V3S-0522-YC8330 | Human membrane spanning 4-domains A1 | IgG1 kappa | WB | ||
| V3S-0622-YC3715 | IgG | ELISA; IHC | 1.91 nM | ||
| V3S-0622-YC3716 | IgG | ELISA; IHC | 3.28 nM | ||
| V3S-0622-YC384 | A recombinant CD20 expressed in E. coli. | IgG1 | ELISA; IHC | ||
| V3S-1022-YC10 | IgG1 | FC | |||
| V3S-1022-YC13 | IgG | FC | |||
| V3S-1022-YC1343 | IgG | ELISA; Cyt | 0.7 nM | ||
| V3S-1022-YC1344 | IgG1 kappa | ELISA | 1.96 nM | ||
| V3S-1022-YC1520 | IgG | ELISA; Cyt | 8.9 nM | ||
| V3S-1022-YC1521 | IgG | ELISA; Cyt | 23.6 nM | ||
| V3S-1022-YC1522 | IgG | ELISA; Cyt | |||
| V3S-1022-YC1576 | IgG | Cyt | 125.6±0.4 nM | ||
| V3S-1022-YC160 | IgG1 | Inhib; ELISA | |||
| V3S-1022-YC1745 | IgG | ELISA; FC | 145 pM | ||
| V3S-1022-YC1848 | IgG | ELISA; FC | |||
| V3S-1022-YC1849 | IgG | ELISA; FC | 0.27±0.02 nM | ||
| V3S-1022-YC2817 | IgG1 | WB; ELISA |
| Description | This product is a human monoclonal antibody that reacts with MS4A1. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Isotype | IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | FuncS |
| Application Notes | The antibody is recommended for detection of MS4A1 by FuncS assay. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | MS4A1 |
| Alternative Name | MS4A1; membrane-spanning 4-domains, subfamily A, member 1; B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16; B-lymphocyte antigen CD20; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1; |
| Gene ID | 931 |
| UniProt | A0A024R507 |
| Research Area | Immunology |
